Anzeige
Meldung des Tages: Deep-Value-Chance: 60 % Insideranteil – warum dieser Gold-Explorer als Geheimtipp gilt

INNOCAP INC News

Aktie
WKN:  ISIN:  US45773A1079 US-Symbol:  INNO
Keine aktuellen Kursdaten verfügbar
Depot/Watchlist
Dieses Wertpapier ist nicht mehr handelbar.
Marktkapitalisierung *
-
Streubesitz
-
KGV
-
Index-Zuordnung
-

INNOCAP INC News

27.01.26 - PR Newswire
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering PR Newswire
27.01.26 - PR Newswire
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering PR Newswire
02.01.26 - PR Newswire
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering PR Newswire
02.01.26 - PR Newswire
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering
Innocan Pharma Corporation Anticipates Listing on the NYSE American Stock Exchange with Concurrent Offering PR Newswire
10.12.25 - PR Newswire
Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering
Innocan Pharma Announces Public Filing of Amended Registration Statement for Proposed U.S. Public Offering PR Newswire
27.11.25 - PR Newswire
Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M
Innocan Pharma Reports Financial Results for Q3 2025, with Revenues at US $21.6M PR Newswire
24.11.25 - PR Newswire
Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats
Innocan Pharma Announces Promising Translational Evidence from a Pain Relief Study of Repeated LPT-CBD Administration in Goats PR Newswire
20.11.25 - PR Newswire
Innocan Pharma announces promising results of LPT-CBD administered to Gottingen Minipigs, a well-known drug toxicology model
Innocan Pharma announces promising results of LPT-CBD administered to Gottingen Minipigs, a well-​known drug toxicology model PR Newswire
24.10.25 - PR Newswire
Innocan Pharma to Present at the 2025 ThinkEquity Conference
Innocan Pharma to Present at the 2025 ThinkEquity Conference PR Newswire
15.10.25 - PR Newswire
Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan
Liposomal CBD Injection Technology (LPT-CBD) patent was allowed in Japan PR Newswire
18.09.25 - PR Newswire
Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection
Innocan Pharma Partners With a Sanctuary For Injured Animals to Bring Remedy and Hope with its LPT-CBD injection PR Newswire
15.09.25 - PR Newswire
Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference
Innocan Pharma's Poster on its Liposomal Synthetic CBD Technology Generates Interest at PAINWeek Conference PR Newswire
29.08.25 - PR Newswire
Innocan Pharma Announces Details of Proposed Share Consolidation
Innocan Pharma Announces Details of Proposed Share Consolidation PR Newswire
27.08.25 - PR Newswire
Innocan Pharma Announces First Half Of 2025 Financial Results
Innocan Pharma Announces First Half Of 2025 Financial Results PR Newswire
22.08.25 - PR Newswire
Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada
Innocan's Findings to be Showcased in Scientific Poster Reception at PAINWeek 2025 Conference in Las Vegas, Nevada PR Newswire
23.07.25 - PR Newswire
Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering
Innocan Pharma Announces Public Filing of Registration Statement for Proposed U.S. Public Offering PR Newswire
03.07.25 - PR Newswire
Innocan Pharma Announces Promising Results of LPT-CBD Administered to Gottingen Minipigs, providing a good translational model and Provides Corporate Update
Innocan Pharma Announces Promising Results of LPT-CBD Administered to Gottingen Minipigs, providing a good translational model and Provides Corporate Update PR Newswire
20.06.25 - PR Newswire
Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference
Innocan Pharma Announces Presentation of Narrative Review on Long-​Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference PR Newswire
13.06.25 - PR Newswire
Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach
Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-​Opioid Analgesic Approach PR Newswire
28.05.25 - PR Newswire
Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update
Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update PR Newswire

Newssuche

Videos

newspaper
03.02.26
2026 02 03 17 34 Trendjumper Einführung
Zunächst inormieren wir unsere Stammkunden bezüglich des bevorstehenden Seminars und bieten für ... Mehr »